Page 1824 - Williams Hematology ( PDFDrive )

1798 Part XI: Malignant Lymphoid Diseases Chapter 109: Macroglobulinemia 1799

56. Cao Y, Hunter ZR, Liu X, et al: CXCR4 WHIM-like frameshift and nonsense mutations 91. Pruzanski W, Shumak KH: Biologic activity of cold-reacting autoantibodies (first of two
promote ibrutinib resistance but do not supplant MYD88 L265P directed signaling in parts). N Engl J Med 297:538, 1977.
Waldenström macroglobulinaemia cells. Br J Haematol 168:701, 2015. 92. Pruzanski W, Shumak KH: Biologic activity of cold-reacting autoantibodies (second of
57. Tournilhac O, Santos DD, Xu L, et al: Mast cells in Waldenström’s macroglobulinemia two parts). N Engl J Med 297:583, 1977.
support lymphoplasmacytic cell growth through CD154/CD40 signaling. Ann Oncol 93. Whittaker SJ, Bhogal BS, Black MM: Acquired immunobullous disease: A cutaneous
17:1275, 2006. manifestation of IgM macroglobulinaemia. Br J Dermatol 135:283, 1996.
58. Zhou Y, Liu X, Xu L, et al: Matrix metalloproteinase-8 is overexpressed in Walden- 94. Daoud MS, Lust JA, Kyle RA, Pittelkow MR: Monoclonal gammopathies and associated
ström’s macroglobulinemia cells, and specific inhibition of this metalloproteinase skin disorders. J Am Acad Dermatol 40:507, 1999.
blocks release of soluble CD27. Clin Lymphoma Myeloma Leuk 11:172, 2011. 95. Gad A, Willen R, Carlen B, et al: Duodenal involvement in Waldenström’s macroglob-
59. Ho AW, Hatjiharissi E, Ciccarelli BT, et al: CD27–CD70 interactions in the pathogenesis ulinemia. J Clin Gastroenterol 20:174, 1995.
of Waldenström macroglobulinemia. Blood 112:4683, 2008. 96. Case records of the Massachusetts General Hospital. Weekly clinicopathological exer-
60. Ngo HT, Leleu X, Lee J, et al: SDF-1/CXCR4 and VLA-4 interaction regulates homing cises. Case 3–1990. A 66-year-old woman with Waldenström’s macroglobulinemia,
in Waldenström macroglobulinemia. Blood 112:150, 2008. diarrhea, anemia, and persistent gastrointestinal bleeding. N Engl J Med 322:183, 1990.
61. Merlini G, Farhangi M, Osserman EF: Monoclonal immunoglobulins with antibody 97. Isaac J, Herrera GA: Cast nephropathy in a case of Waldenström’s macroglobulinemia.
activity in myeloma, macroglobulinemia and related plasma cell dyscrasias. Semin Nephron 91:512, 2002.
Oncol 13:350, 1986. 98. Morel-Maroger L, Basch A, Danon F, et al: Pathology of the kidney in Waldenström’s
62. Farhangi M, Merlini G: The clinical implications of monoclonal immunoglobulins. macroglobulinemia. Study of sixteen cases. N Engl J Med 283:123, 1970.
Semin Oncol 13:366, 1986. 99. Gertz MA, Kyle RA, Noel P: Primary systemic amyloidosis: A rare complication of
63. Marmont AM, Merlini G: Monoclonal autoimmunity in hematology. Haematologica immunoglobulin M monoclonal gammopathies and Waldenström’s macroglobuline-
76:449, 1991. mia. J Clin Oncol 11:914, 1993.
64. Mackenzie MR, Babcock J: Studies of the hyperviscosity syndrome. II: Macroglobuline- 100. Moyner K, Sletten K, Husby G, Natvig JB: An unusually large (83 amino acid residues)
mia. J Lab Clin Med 85:227, 1975. amyloid fibril protein AA from a patient with Waldenström’s macroglobulinaemia and
65. Gertz MA, Kyle RA: Hyperviscosity syndrome. J Intensive Care Med 10:128, 1995. amyloidosis. Scand J Immunol 11:549, 1980.
66. Kwaan HC, Bongu A: The hyperviscosity syndromes. Semin Thromb Hemost 25:199, 101. Gardyn J, Schwartz A, Gal R, et al: Waldenström’s macroglobulinemia associated with
1999. AA amyloidosis. Int J Hematol 74:76, 2001.
67. Singh A, Eckardt KU, Zimmermann A, et al: Increased plasma viscosity as a reason for 102. Dussol B, Kaplanski G, Daniel L, et al: Simultaneous occurrence of fibrillary glomerul-
inappropriate erythropoietin formation. J Clin Invest 91:251, 1993. opathy and AL amyloid. Nephrol Dial Transplant 13:2630, 1998.
68. Menke MN, Feke GT, McMeel JW, et al: Hyperviscosity-related retinopathy in Walden- 103. Rausch PG, Herion JC: Pulmonary manifestations of Waldenström macroglobuline-
ström’s macroglobulinemia. Arch Ophthalmol 124:1601, 2006. mia. Am J Hematol 9:201, 1980.
69. Merlini G, Baldini L, Broglia C, et al: Prognostic factors in symptomatic Waldenström’s 104. Fadil A, Taylor DE: The lung and Waldenström’s macroglobulinemia. South Med J
macroglobulinemia. Semin Oncol 30:211, 2003. 91:681, 1998.
70. Stone MJ: Waldenström’s macroglobulinemia: hyperviscosity syndrome and cryoglob- 105. Kyrtsonis MC, Angelopoulou MK, Kontopidou FN, et al: Primary lung involvement in
ulinemia. Clin Lymphoma Myeloma 9:97, 2009. Waldenström’s macroglobulinaemia: Report of two cases and review of the literature.
71. Dellagi K, Dupouey P, Brouet JC, et al: Waldenström’s macroglobulinemia and periph- Acta Haematol 105:92, 2001.
eral neuropathy: A clinical and immunologic study of 25 patients. Blood 62:280, 106. Kaila VL, el Newihi HM, Dreiling BJ, et al: Waldenström’s macroglobulinemia of the
1983. stomach presenting with upper gastrointestinal hemorrhage. Gastrointest Endosc 44:73,
72. Nobile-Orazio E, Marmiroli P, Baldini L, et al: Peripheral neuropathy in macroglobu- 1996.
linemia: Incidence and antigen-specificity of M proteins. Neurology 37:1506, 1987. 107. Yasui O, Tukamoto F, Sasaki N, et al: Malignant lymphoma of the transverse colon asso-
73. Treon SP, Hanzis C, Ioakimidis L, et al: Clinical characteristics and treatment outcome ciated with macroglobulinemia. Am J Gastroenterol 92:2299, 1997.
of disease-related peripheral neuropathy in Waldenström’s macroglobulinemia (WM). 108. Rosenthal JA, Curran WJ Jr, Schuster SJ: Waldenström’s macroglobulinemia resulting
J Clin Oncol 28:15s (Abstract 8114), 2010. from localized gastric lymphoplasmacytoid lymphoma. Am J Hematol 58:244, 1998.
74. Nemni R, Gerosa E, Piccolo G, Merlini G: Neuropathies associated with monoclonal 109. Recine MA, Perez MT, Cabello-Inchausti B, et al: Extranodal lymphoplasmacytoid lym-
gammopathies. Haematologica 79:557, 1994. phoma (immunocytoma) presenting as small intestinal obstruction. Arch Pathol Lab
75. Ropper AH, Gorson KC: Neuropathies associated with paraproteinemia. N Engl J Med Med 125:677, 2001.
338:1601, 1998. 110. Veltman GA, van Veen S, Kluin-Nelemans JC, et al: Renal disease in Waldenström’s
76. Vital A: Paraproteinemic neuropathies. Brain Pathol 11:399, 2001. macroglobulinaemia. Nephrol Dial Transplant 12:1256, 1997.
77. Latov N, Braun PE, Gross RB, et al: Plasma cell dyscrasia and peripheral neuropathy: 111. Moore DF Jr, Moulopoulos LA, Dimopoulos MA: Waldenström macroglobuline-
Identification of the myelin antigens that react with human paraproteins. Proc Natl mia presenting as a renal or perirenal mass: Clinical and radiographic features. Leuk
Acad Sci U S A 78:7139, 1981. Lymphoma 17:331, 1995.
78. Chassande B, Leger JM, Younes-Chennoufi AB, et al: Peripheral neuropathy associated 112. Mascaro JM, Montserrat E, Estrach T, et al: Specific cutaneous manifestations of
with IgM monoclonal gammopathy: Correlations between M-protein antibody activity Waldenström’s macroglobulinaemia. A report of two cases. Br J Dermatol 106:17, 1982.
and clinical/electrophysiological features in 40 cases. Muscle Nerve 21:55, 1998. 113. Schnitzler L, Schubert B, Boasson M, et al: Urticaire chronique, lésions osseuses, mac-
79. Weiss MD, Dalakas MC, Lauter CJ, et al: Variability in the binding of anti-MAG and roglobulinémie IgM: Maladie de Waldenström? Bull Soc Fr Dermatol Syphiligr 81:
anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM para- 363, 1974.
proteinemia. J Neuroimmunol 95:174, 1999. 114. Roux S, Fermand JP, Brechignac S, et al: Tumoral joint involvement in multiple myeloma
80. Latov N, Hays AP, Sherman WH: Peripheral neuropathy and anti-MAG antibodies. Crit and Waldenström’s macroglobulinemia—Report of 4 cases. J Rheumatol 23:2175, 1996.
Rev Neurobiol 3:301, 1988. 115. Orellana J, Friedman AH: Ocular manifestations of multiple myeloma, Waldenström’s
81. Dalakas MC, Quarles RH: Autoimmune ataxic neuropathies (sensory ganglionopa- macroglobulinemia and benign monoclonal gammopathy. Surv Ophthalmol 26:157,
thies): Are glycolipids the responsible autoantigens? Ann Neurol 39:419, 1996. 1981.
82. Eurelings M, Ang CW, Notermans NC, et al: Antiganglioside antibodies in polyneurop- 116. Ettl AR, Birbamer GG, Philipp W: Orbital involvement in Waldenström’s macro-
athy associated with monoclonal gammopathy. Neurology 57:1909, 2001. globulinemia: Ultrasound, computed tomography and magnetic resonance findings.
83. Ilyas AA, Quarles RH, Dalakas MC, et al: Monoclonal IgM in a patient with para- Ophthalmologica 205:40, 1992.
proteinemic polyneuropathy binds to gangliosides containing disialosyl groups. Ann 117. Civit T, Coulbois S, Baylac F, et al: [Waldenström’s macroglobulinemia and cerebral
Neurol 18:655, 1985. lymphoplasmacytic proliferation: Bing and Neel syndrome. Apropos of a new case.] [in
84. Willison HJ, O’Leary CP, Veitch J, et al: The clinical and laboratory features of chronic French] Neurochirurgie 43:245, 1997.
sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 124:1968, 2001. 118. Ciccarelli BT, Patterson CJ, Hunter ZR, et al: Hepcidin is produced by lymphoplasma-
85. Lopate G, Choksi R, Pestronk A: Severe sensory ataxia and demyelinating polyneurop- cytic cells and is associated with anemia in Waldenström’s macroglobulinemia. Clin
athy with IgM anti-GM and GalNAc-GD1A antibodies. Muscle Nerve 25:828, 2002. Lymphoma Myeloma Leuk 11:160, 2011.
2
86. Jacobs BC, O’Hanlon GM, Breedland EG, et al: Human IgM paraproteins demon- 119. Treon SP, Tripsas C, Ciccarelli BT, et al: Patients with Waldenström macroglobulinemia
strate shared reactivity between Campylobacter jejuni lipopolysaccharides and human commonly present with iron deficiency and those with severely depressed transferrin
peripheral nerve disialylated gangliosides. J Neuroimmunol 80:23, 1997. saturation levels show response to parenteral iron administration. Clin Lymphoma
87. Nobile-Orazio E, Manfredini E, Carpo M, et al: Frequency and clinical correlates of Myeloma Leuk 13:241, 2013.
antineural IgM antibodies in neuropathy associated with IgM monoclonal gammopa- 120. Owen RG, Barrans SL, Richards SJ, et al: Waldenström macroglobulinemia. Develop-
thy. Ann Neurol 36:416, 1994. ment of diagnostic criteria and identification of prognostic factors. Am J Clin Pathol
88. Gordon PH, Rowland LP, Younger DS, et al: Lymphoproliferative disorders and motor 116:420, 2001.
neuron disease: An update. Neurology 48:1671, 1997. 121. Feiner HD, Rizk CC, Finfer MD, et al: IgM monoclonal gammopathy/Waldenström’s
89. Pavord SR, Murphy PT, Mitchell VE: POEMS syndrome and Waldenström’s macro- macroglobulinemia: A morphological and immunophenotypic study of the bone mar-
globulinaemia. J Clin Pathol 49:181, 1996. row. Mod Pathol 3:348, 1990.
90. Crisp D, Pruzanski W: B-cell neoplasms with homogeneous cold-reacting antibodies 122. Dutcher TF, Fahey JL: The histopathology of macroglobulinemia of Waldenström.
(cold agglutinins). Am J Med 72:915, 1982. J Natl Cancer Inst 22:887, 1959.

Kaushansky_chapter 109_p1785-1802.indd 1799 9/21/15 12:31 PM